Completion of pharmacokinetic (PK) and pharmacodynamics (PD) studies to provide essential data on how a target drug candidate is processed and delivered to the lung and assessing therapeutic effects.
NuvoBio Corporation
3 enregistrements totalisant 90,000.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $90,000 | 3 enregistrements |
Enregistrements
NuvoBio Corporation
$30,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Youth Employment Program
EF 2024-2025
Canada
NuvoBio Corporation
$30,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Youth Employment Program
EF 2025-2026
Canada
Pre-clinical proof-of-concept studies to assess therapeutic activity in an mRNA-LNP Delivered SMYD3 Peptide Therapeutic both patient-derived cell lines and a murine xenograft model of SCLC. Conduct in...
NuvoBio Corporation
$30,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Youth Employment Program
EF 2026-2027
Canada
Experimental workflows required to advance and validate peptide candidates, generate biochemical data, and meet defined project milestones. Specific focus on peptide handling, biochemical assays, and...